Operating Expenses Summary of Novo Nordisk A/S

Novo Nordisk A/S's latest annual operating expenses in 2023 was 93.92 Billion DKK , up 27.44% from previous year.
Novo Nordisk A/S's latest quarterly operating expenses in 2024 Q2 was 32.25 Billion DKK , up 38.37% from previous quarter.
Novo Nordisk A/S reported a annual operating expenses of 73.69 Billion DKK in annual operating expenses 2022, up 25.98% from previous year.
Novo Nordisk A/S reported a annual operating expenses of 58.49 Billion DKK in annual operating expenses 2021, up 12.74% from previous year.
Novo Nordisk A/S reported a quarterly operating expenses of 23.01 Billion DKK for 2024 Q1, down -20.85% from previous quarter.
Novo Nordisk A/S reported a quarterly operating expenses of 29.08 Billion DKK for 2023 Q4, up 31.57% from previous quarter.

Annual Operating Expenses Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Operating Expenses of Novo Nordisk A/S (2023 - 1989)

Year	Operating Expenses	Operating Expenses Growth
2023	93.92 Billion DKK	27.44%
2022	73.69 Billion DKK	25.98%
2021	58.49 Billion DKK	12.74%
2020	51.88 Billion DKK	4.93%
2019	49.45 Billion DKK	5.29%
2018	46.96 Billion DKK	4.14%
2017	45.09 Billion DKK	-2.31%
2016	46.16 Billion DKK	9.15%
2015	42.29 Billion DKK	6.4%
2014	39.75 Billion DKK	4.78%
2013	37.93 Billion DKK	8.13%
2012	35.08 Billion DKK	10.07%
2011	31.87 Billion DKK	1.14%
2010	31.51 Billion DKK	21.0%
2009	26.04 Billion DKK	12.64%
2008	23.12 Billion DKK	-0.0%
2007	23.12 Billion DKK	15.38%
2006	20.04 Billion DKK	21.68%
2005	16.47 Billion DKK	16.84%
2004	14.09 Billion DKK	10.54%
2003	12.75 Billion DKK	1.58%
2002	12.55 Billion DKK	3.3%
2001	12.15 Billion DKK	-0.3%
2000	12.19 Billion DKK	-0.71%
1999	12.27 Billion DKK	7.19%
1998	11.45 Billion DKK	15.39%
1997	9.92 Billion DKK	13.38%
1996	8.75 Billion DKK	9.31%
1995	8.01 Billion DKK	2.12%
1994	7.84 Billion DKK	63.63%
1993	4.79 Billion DKK	-31.38%
1992	6.98 Billion DKK	92.43%
1991	3.63 Billion DKK	15.09%
1990	3.15 Billion DKK	12.48%
1989	2.8 Billion DKK	41.85%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	32.25 Billion DKK	38.37%
2024 Q1	23.01 Billion DKK	-20.85%
2023 Q4	29.08 Billion DKK	31.57%
2023 Q1	20.17 Billion DKK	-11.28%
2023 FY	93.92 Billion DKK	27.44%
2023 Q3	22.1 Billion DKK	-2.0%
2023 Q2	22.55 Billion DKK	11.79%
2022 Q1	15.96 Billion DKK	-13.5%
2022 Q4	22.74 Billion DKK	25.09%
2022 Q3	18.18 Billion DKK	8.19%
2022 FY	73.69 Billion DKK	25.98%
2022 Q2	16.8 Billion DKK	5.25%
2021 Q1	13.01 Billion DKK	-15.19%
2021 Q4	18.45 Billion DKK	28.95%
2021 Q3	14.31 Billion DKK	12.58%
2021 Q2	12.71 Billion DKK	-2.27%
2021 FY	58.49 Billion DKK	12.74%
2020 Q2	11.39 Billion DKK	-6.49%
2020 Q1	12.18 Billion DKK	-19.36%
2020 FY	51.88 Billion DKK	4.93%
2020 Q4	15.34 Billion DKK	18.34%
2020 Q3	12.96 Billion DKK	13.76%
2019 Q3	12.28 Billion DKK	4.67%
2019 Q1	10.32 Billion DKK	-27.81%
2019 Q2	11.73 Billion DKK	13.71%
2019 Q4	15.11 Billion DKK	23.03%
2019 FY	49.45 Billion DKK	5.29%
2018 Q4	14.29 Billion DKK	23.95%
2018 Q3	11.53 Billion DKK	6.29%
2018 Q2	10.85 Billion DKK	5.5%
2018 Q1	10.28 Billion DKK	-22.35%
2018 FY	46.96 Billion DKK	4.14%
2017 FY	45.09 Billion DKK	-2.31%
2017 Q4	13.24 Billion DKK	28.62%
2017 Q3	10.29 Billion DKK	-5.03%
2017 Q2	10.84 Billion DKK	1.23%
2017 Q1	10.71 Billion DKK	-20.35%
2016 Q2	10.91 Billion DKK	2.32%
2016 Q1	10.66 Billion DKK	-18.82%
2016 FY	46.16 Billion DKK	9.15%
2016 Q3	11.13 Billion DKK	1.96%
2016 Q4	13.44 Billion DKK	20.82%
2015 FY	42.29 Billion DKK	6.4%
2015 Q3	10.96 Billion DKK	2.3%
2015 Q1	7.46 Billion DKK	-34.65%
2015 Q4	13.14 Billion DKK	19.86%
2015 Q2	10.71 Billion DKK	43.5%
2014 Q1	8.84 Billion DKK	-19.19%
2014 FY	39.75 Billion DKK	4.78%
2014 Q4	11.42 Billion DKK	11.46%
2014 Q3	10.25 Billion DKK	11.15%
2014 Q2	9.22 Billion DKK	4.31%
2013 FY	37.93 Billion DKK	8.13%
2013 Q3	8.99 Billion DKK	-2.12%
2013 Q1	8.81 Billion DKK	-9.41%
2013 Q2	9.18 Billion DKK	4.28%
2013 Q4	10.94 Billion DKK	21.68%
2012 FY	35.08 Billion DKK	10.07%
2012 Q3	8.68 Billion DKK	3.47%
2012 Q2	8.39 Billion DKK	3.17%
2012 Q1	8.13 Billion DKK	-13.58%
2012 Q4	9.72 Billion DKK	12.04%
2011 Q3	7.67 Billion DKK	0.45%
2011 FY	31.87 Billion DKK	1.14%
2011 Q4	9.41 Billion DKK	22.68%
2011 Q2	7.63 Billion DKK	4.53%
2011 Q1	7.3 Billion DKK	3.6%
2010 Q2	7.38 Billion DKK	11.84%
2010 Q1	6.6 Billion DKK	-12.54%
2010 Q4	7.05 Billion DKK	-8.94%
2010 FY	31.51 Billion DKK	21.0%
2010 Q3	7.74 Billion DKK	4.88%
2009 Q4	7.54 Billion DKK	25.44%
2009 FY	26.04 Billion DKK	12.64%
2009 Q2	6.45 Billion DKK	4.48%
2009 Q1	6.18 Billion DKK	-8.32%
2009 Q3	6.01 Billion DKK	-6.8%
2008 FY	23.12 Billion DKK	-0.0%
2008 Q2	5.71 Billion DKK	6.47%
2008 Q3	5.31 Billion DKK	-7.0%
2008 Q4	6.74 Billion DKK	26.92%
2008 Q1	5.36 Billion DKK	-26.05%
2007 FY	23.12 Billion DKK	15.38%
2007 Q2	5.39 Billion DKK	4.31%
2007 Q3	5.3 Billion DKK	-1.66%
2007 Q4	7.25 Billion DKK	36.67%
2007 Q1	5.17 Billion DKK	-10.75%
2006 Q3	4.74 Billion DKK	-2.03%
2006 Q2	4.84 Billion DKK	4.25%
2006 FY	20.04 Billion DKK	21.68%
2006 Q4	5.79 Billion DKK	22.11%
2006 Q1	4.64 Billion DKK	-6.4%
2005 Q1	3.66 Billion DKK	-6.86%
2005 FY	16.47 Billion DKK	16.84%
2005 Q4	4.96 Billion DKK	20.38%
2005 Q3	4.12 Billion DKK	10.79%
2005 Q2	3.72 Billion DKK	1.55%
2004 Q3	3.6 Billion DKK	9.69%
2004 FY	14.09 Billion DKK	10.54%
2004 Q4	3.93 Billion DKK	9.27%
2004 Q2	3.28 Billion DKK	3.34%
2004 Q1	3.17 Billion DKK	-67.29%
2003 Q1	972 Million DKK	105.07%
2003 Q4	9.71 Billion DKK	824.38%
2003 Q3	1.05 Billion DKK	5.01%
2003 Q2	1 Billion DKK	2.97%
2003 FY	12.75 Billion DKK	1.58%
2002 FY	12.55 Billion DKK	3.3%
2002 Q2	- DKK	0.0%
2002 Q1	- DKK	100.0%
2002 Q3	- DKK	0.0%
2002 Q4	-19.18 Billion DKK	0.0%
2001 Q2	- DKK	0.0%
2001 Q1	- DKK	100.0%
2001 FY	12.15 Billion DKK	-0.3%
2001 Q4	-18.11 Billion DKK	0.0%
2001 Q3	- DKK	0.0%
2000 Q4	-16.57 Billion DKK	0.0%
2000 FY	12.19 Billion DKK	-0.71%
2000 Q3	- DKK	0.0%
2000 Q2	- DKK	0.0%
2000 Q1	- DKK	100.0%
1999 Q1	- DKK	100.0%
1999 FY	12.27 Billion DKK	7.19%
1999 Q4	-17.32 Billion DKK	0.0%
1999 Q3	- DKK	0.0%
1999 Q2	- DKK	0.0%
1998 FY	11.45 Billion DKK	15.39%
1998 Q2	- DKK	0.0%
1998 Q1	- DKK	100.0%
1998 Q3	- DKK	0.0%
1998 Q4	-15.84 Billion DKK	0.0%
1997 Q3	- DKK	0.0%
1997 FY	9.92 Billion DKK	13.38%
1997 Q1	- DKK	100.0%
1997 Q2	- DKK	0.0%
1997 Q4	-14.64 Billion DKK	0.0%
1996 FY	8.75 Billion DKK	9.31%
1996 Q4	-12.92 Billion DKK	0.0%
1996 Q3	- DKK	0.0%
1996 Q2	- DKK	0.0%
1996 Q1	- DKK	100.0%
1995 Q2	- DKK	0.0%
1995 Q1	- DKK	100.0%
1995 Q3	- DKK	0.0%
1995 FY	8.01 Billion DKK	2.12%
1995 Q4	-11.84 Billion DKK	0.0%
1994 FY	7.84 Billion DKK	63.63%
1994 Q1	- DKK	100.0%
1994 Q2	- DKK	0.0%
1994 Q3	- DKK	0.0%
1994 Q4	-11.67 Billion DKK	0.0%
1993 Q4	-11.2 Billion DKK	0.0%
1993 Q1	- DKK	100.0%
1993 Q2	- DKK	0.0%
1993 Q3	- DKK	0.0%
1993 FY	4.79 Billion DKK	-31.38%
1992 Q3	- DKK	0.0%
1992 Q4	-9.51 Billion DKK	0.0%
1992 Q2	- DKK	0.0%
1992 FY	6.98 Billion DKK	92.43%
1992 Q1	- DKK	100.0%
1991 Q1	- DKK	100.0%
1991 Q2	- DKK	0.0%
1991 FY	3.63 Billion DKK	15.09%
1991 Q4	-8.42 Billion DKK	0.0%
1991 Q3	- DKK	0.0%
1990 Q1	- DKK	100.0%
1990 Q3	- DKK	0.0%
1990 FY	3.15 Billion DKK	12.48%
1990 Q4	-7.27 Billion DKK	0.0%
1990 Q2	- DKK	0.0%
1989 Q3	- DKK	0.0%
1989 Q1	- DKK	100.0%
1989 FY	2.8 Billion DKK	41.85%
1989 Q4	-6.56 Billion DKK	0.0%
1989 Q2	- DKK	0.0%

Peer Operating Expenses Comparison of Novo Nordisk A/S

Name	Operating Expenses	Operating Expenses Difference
ADC Therapeutics SA	233.01 Million USD	-40207.276%
Alto Neuroscience, Inc.	37.8 Million USD	-248311.754%
Annovis Bio, Inc.	45.03 Million USD	-208453.296%
Biohaven Pharmaceutical Holding Company Ltd.	436.05 Million USD	-21439.224%
Ginkgo Bioworks Holdings, Inc.	1.1 Billion USD	-8373.809%
Nuvation Bio Inc.	99.82 Million USD	-93989.479%
Nuvation Bio Inc.	99.82 Million USD	-93989.479%
Arcus Biosciences, Inc.	457 Million USD	-20451.86%
Theriva Biologics, Inc.	21.43 Million USD	-438152.998%
Zymeworks Inc.	196.76 Million USD	-47634.296%

Global Stocks Search

Novo Nordisk A/S (NVO)

Operating Expenses Summary of Novo Nordisk A/S

Annual Operating Expenses Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Operating Expenses of Novo Nordisk A/S (2023 - 1989)

Peer Operating Expenses Comparison of Novo Nordisk A/S